Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anifrolumab Real-world Treatment Outcomes in Polish Patients With Systemic Lupus Erythematosus (SLE). Multicenter, Non-interventional Study

NCT06673043 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06673043
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06673043 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anifrolumab Real-world Treatment Outcomes in Polish Patients With Systemic Lupus Erythematosus (SLE). Multicenter, Non-interventional Study
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Active, not recruiting
Start date
February 28, 2025
Completion date
June 30, 2028
Enrollment
105 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

lupus erythematosus, systemic